AK Medical Executes HKD 7.19 Million Share Buyback, Lifts Mandate Utilisation to 3.62%

Bulletin Express

Mar 26

AK Medical Holdings Limited announced that it repurchased 1.19 million ordinary shares on 26 March 2026 via on-market transactions at HKD 6.02 per share, for a total consideration of HKD 7.19 million.

Including this latest transaction, the company has bought back 4.06 million shares since receiving the share-repurchase mandate on 18 June 2025, utilising 3.62% of the 112.27 million shares authorised for buyback.

Key data from the filing:

• Latest repurchase – Volume: 1.19 million shares – Price: HKD 6.02 per share (single-price trade) – Cash outlay: HKD 7.19 million – Shares will be cancelled; no treasury shares were held post-repurchase.

• Cumulative outstanding cancellations (not yet effected) – 06 Feb 2026: 0.64 million shares at HKD 5.92 – 13 Feb 2026: 1.09 million shares at HKD 6.21 – 16 Feb 2026: 1.14 million shares at HKD 6.18 – 26 Mar 2026: 1.19 million shares at HKD 6.02

• Share capital position – Opening and closing issued shares (excluding treasury shares): 1.124 billion – No treasury shares were outstanding as of 26 March 2026.

The company is restricted from issuing new shares or selling any treasury shares until 25 April 2026, reflecting the 30-day moratorium following the repurchase. All transactions were executed under the board-approved mandate and complied with Hong Kong Stock Exchange requirements, according to the company secretary’s confirmation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1161730072"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1161730072\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1161730072?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-26 19:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161730072","market":"us","top_or_hot":-1,"title":"AK Medical Executes HKD 7.19 Million Share Buyback, Lifts Mandate Utilisation to 3.62%","media":"Bulletin Express","content":"<p>AK Medical Holdings Limited announced that it repurchased 1.19 million ordinary shares on 26 March 2026 via on-market transactions at HKD 6.02 per share, for a total consideration of HKD 7.19 million.</p>\n<p>Including this latest transaction, the company has bought back 4.06 million shares since receiving the share-repurchase mandate on 18 June 2025, utilising 3.62% of the 112.27 million shares authorised for buyback.</p>\n<p>Key data from the filing:</p>\n<p>• Latest repurchase  \n  – Volume: 1.19 million shares  \n  – Price: HKD 6.02 per share (single-price trade)  \n  – Cash outlay: HKD 7.19 million  \n  – Shares will be cancelled; no treasury shares were held post-repurchase.</p>\n<p>• Cumulative outstanding cancellations (not yet effected)  \n  – 06 Feb 2026: 0.64 million shares at HKD 5.92  \n  – 13 Feb 2026: 1.09 million shares at HKD 6.21  \n  – 16 Feb 2026: 1.14 million shares at HKD 6.18  \n  – 26 Mar 2026: 1.19 million shares at HKD 6.02</p>\n<p>• Share capital position  \n  – Opening and closing issued shares (excluding treasury shares): 1.124 billion  \n  – No treasury shares were outstanding as of 26 March 2026.</p>\n<p>The company is restricted from issuing new shares or selling any treasury shares until 25 April 2026, reflecting the 30-day moratorium following the repurchase. All transactions were executed under the board-approved mandate and complied with Hong Kong Stock Exchange requirements, according to the company secretary’s confirmation.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AK Medical Executes HKD 7.19 Million Share Buyback, Lifts Mandate Utilisation to 3.62%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAK Medical Executes HKD 7.19 Million Share Buyback, Lifts Mandate Utilisation to 3.62%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-26 19:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AK Medical Holdings Limited announced that it repurchased 1.19 million ordinary shares on 26 March 2026 via on-market transactions at HKD 6.02 per share, for a total consideration of HKD 7.19 million.</p>\n<p>Including this latest transaction, the company has bought back 4.06 million shares since receiving the share-repurchase mandate on 18 June 2025, utilising 3.62% of the 112.27 million shares authorised for buyback.</p>\n<p>Key data from the filing:</p>\n<p>• Latest repurchase  \n  – Volume: 1.19 million shares  \n  – Price: HKD 6.02 per share (single-price trade)  \n  – Cash outlay: HKD 7.19 million  \n  – Shares will be cancelled; no treasury shares were held post-repurchase.</p>\n<p>• Cumulative outstanding cancellations (not yet effected)  \n  – 06 Feb 2026: 0.64 million shares at HKD 5.92  \n  – 13 Feb 2026: 1.09 million shares at HKD 6.21  \n  – 16 Feb 2026: 1.14 million shares at HKD 6.18  \n  – 26 Mar 2026: 1.19 million shares at HKD 6.02</p>\n<p>• Share capital position  \n  – Opening and closing issued shares (excluding treasury shares): 1.124 billion  \n  – No treasury shares were outstanding as of 26 March 2026.</p>\n<p>The company is restricted from issuing new shares or selling any treasury shares until 25 April 2026, reflecting the 30-day moratorium following the repurchase. All transactions were executed under the board-approved mandate and complied with Hong Kong Stock Exchange requirements, according to the company secretary’s confirmation.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01789","symbol_name":"爱康医疗","start_time":0,"source_url":"","article_id":"1161730072","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161730072","pubTimestamp":1774524181,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"AK Medical Holdings Limited announced that it repurchased 1.19 million ordinary shares on 26 March 2026 via on-market transactions at HKD 6.02 per share, for a total consideration of HKD 7.19...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01789":"爱康医疗"},"translate_title":"爱康医疗执行719万港元股份回购，授权使用率提升至3.62%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01789":1},"content_text":"AK Medical Holdings Limited announced that it repurchased 1.19 million ordinary shares on 26 March 2026 via on-market transactions at HKD 6.02 per share, for a total consideration of HKD 7.19 million.\nIncluding this latest transaction, the company has bought back 4.06 million shares since receiving the share-repurchase mandate on 18 June 2025, utilising 3.62% of the 112.27 million shares authorised for buyback.\nKey data from the filing:\n• Latest repurchase  \n  – Volume: 1.19 million shares  \n  – Price: HKD 6.02 per share (single-price trade)  \n  – Cash outlay: HKD 7.19 million  \n  – Shares will be cancelled; no treasury shares were held post-repurchase.\n• Cumulative outstanding cancellations (not yet effected)  \n  – 06 Feb 2026: 0.64 million shares at HKD 5.92  \n  – 13 Feb 2026: 1.09 million shares at HKD 6.21  \n  – 16 Feb 2026: 1.14 million shares at HKD 6.18  \n  – 26 Mar 2026: 1.19 million shares at HKD 6.02\n• Share capital position  \n  – Opening and closing issued shares (excluding treasury shares): 1.124 billion  \n  – No treasury shares were outstanding as of 26 March 2026.\nThe company is restricted from issuing new shares or selling any treasury shares until 25 April 2026, reflecting the 30-day moratorium following the repurchase. All transactions were executed under the board-approved mandate and complied with Hong Kong Stock Exchange requirements, according to the company secretary’s confirmation.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}